<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4489F2C4-061B-49A9-9E72-9ACC7ECCA2AF"><gtr:id>4489F2C4-061B-49A9-9E72-9ACC7ECCA2AF</gtr:id><gtr:name>Derriford Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8525C80A-080A-4EC7-90F8-ED6BB8560C64"><gtr:id>8525C80A-080A-4EC7-90F8-ED6BB8560C64</gtr:id><gtr:name>Animal Health and Veterinary Laboratories Agency (AHVLA)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EAF17943-4FDF-4E08-A8D2-281D7130987C"><gtr:id>EAF17943-4FDF-4E08-A8D2-281D7130987C</gtr:id><gtr:name>Birkbeck, University of London</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C1ED9692-B6AE-4778-BF31-AE813E8E4415"><gtr:id>C1ED9692-B6AE-4778-BF31-AE813E8E4415</gtr:id><gtr:name>MRC Prion Unit</gtr:name><gtr:address><gtr:line1>MRC Prion Unit</gtr:line1><gtr:line2>Institute of Neurology</gtr:line2><gtr:line3>Queen Square</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>WC1N 3BG</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C1ED9692-B6AE-4778-BF31-AE813E8E4415"><gtr:id>C1ED9692-B6AE-4778-BF31-AE813E8E4415</gtr:id><gtr:name>MRC Prion Unit</gtr:name><gtr:address><gtr:line1>MRC Prion Unit</gtr:line1><gtr:line2>Institute of Neurology</gtr:line2><gtr:line3>Queen Square</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>WC1N 3BG</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4489F2C4-061B-49A9-9E72-9ACC7ECCA2AF"><gtr:id>4489F2C4-061B-49A9-9E72-9ACC7ECCA2AF</gtr:id><gtr:name>Derriford Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8525C80A-080A-4EC7-90F8-ED6BB8560C64"><gtr:id>8525C80A-080A-4EC7-90F8-ED6BB8560C64</gtr:id><gtr:name>Animal Health and Veterinary Laboratories Agency (AHVLA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EAF17943-4FDF-4E08-A8D2-281D7130987C"><gtr:id>EAF17943-4FDF-4E08-A8D2-281D7130987C</gtr:id><gtr:name>Birkbeck, University of London</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/50B70C44-B5B3-4AA2-9299-CC4EE9CF5E20"><gtr:id>50B70C44-B5B3-4AA2-9299-CC4EE9CF5E20</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:surname>Wadsworth</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0E953CEB-E92F-4800-AFDB-D7FB776FE5B5"><gtr:id>0E953CEB-E92F-4800-AFDB-D7FB776FE5B5</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Collinge</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U123160655"><gtr:id>1222C77D-418F-4B59-A4E6-6E4A49D5F9D6</gtr:id><gtr:title>Molecular and phenotypic analysis of human prion strains</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U123160655</gtr:grantReference><gtr:abstractText>Prions, the infectious agents causing BSE in cows and variant CJD in humans are unique in medical research. Unlike all other infectious agents (bacteria and viruses) the infectious particle does not contain genetic information (genes) but instead consists of a protein (called PrPSc). Although prions do not carry genetic material they come in several different forms, called prion strains that cause different forms of the disease. Our research aims to understand the fundamental biology of what makes prion strains different from one another and why some are able to cross from animals to humans to cause disease. Understanding these differences is vital to providing early diagnosis and to developing effective cures that halt the spread of prion infection and prevent fatal brain damage.||Our research focuses on isolating infectious prion particles from diseased tissue and using sophisticated equipment to study their chemical makeup. Through these studies we aim to provide a detailed description of the protein (PrPSc) associated with each prion strain and pinpoint exactly what differences are responsible for a particular form of disease. For some studies we use a prion strain (RML prions) that can be detected in isolated cells allowing us to make much faster progress than has been previously possible. In other studies we use genetically altered mice (transgenic mice) to understand which animal prion strains may pose a risk to humans and to see what these diseases may look like should people become infected. These studies have confirmed that variant CJD is caused by the same prion strain that causes BSE in cows and have established that a persons genetic makeup may influence the type of prion disease they will develop if infected with BSE prions.||Because of the very long time periods possible between infection and the appearance of symptoms the number of people with BSE infection is unknown. This has raised fears that infected people who have no signs of the disease might pass it on to others by surgery, blood transfusion and other medical routes. We have pioneered laboratory tests to rapidly detect variant CJD and other forms of disease caused by BSE infection should they occur. Our findings have been used throughout the world to help accurately diagnose human prion diseases and have assisted the World Health Organisation to develop measures to limit the spread of these diseases from one person to another by medical procedures.</gtr:abstractText><gtr:technicalSummary>Prion diseases are fatal neurodegenerative disorders that include scrapie in sheep, bovine spongiform encephalopathy (BSE) in cattle, Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler-Scheinker disease (GSS), fatal familial insomnia (FFI), kuru and most recently variant CJD (vCJD) in humans. Their central feature is the conversion of a normal host protein, the cellular prion protein (PrPC), to an abnormal isoform, designated PrPSc. This transition appears to involve only conformational change rather than covalent modification and confers PrPSc with resistance to proteolytic degradation and detergent insolubility. The marked clinical heterogeneity observed in human prion diseases has yet to be explained. However, it has been clear for many years that distinct isolates, or strains, of prions can be propagated in the same host and these are biologically recognised by distinctive clinical and pathological features. It is therefore likely that a proportion of clinicopathological heterogeneity seen human prion diseases relate to the propagation of distinct human prion strains. How this strain diversity is encoded by an apparently protein-only agent remains one of the most interesting and challenging questions in biology. Although distinct mammalian prion strains are associated with different prion protein conformations and glycoform assembly states their precise composition and the molecular determinants of strain remain unknown. Our integrated series of research projects aim to define the molecular composition and ultra-structure of infectious prions and elucidate the molecular basis of prion strain diversity. Knowledge generated by this research is expected to have direct translational benefit by facilitating improved methods of diagnosis and therapeutic treatments for human prion disease.</gtr:technicalSummary><gtr:fund><gtr:end>2017-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>8961322</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Animal Health And Veterinary Laboratories Agency (AHVLA)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Investigation of ovine prions</gtr:description><gtr:id>DAF797DF-B472-48EC-8758-E315F0B8B250</gtr:id><gtr:impact>Publication
PMID:24188521</gtr:impact><gtr:outcomeId>dbyTEKpKFvX-1</gtr:outcomeId><gtr:partnerContribution>Provision of biological materials and data</gtr:partnerContribution><gtr:piContribution>Transmission studies of natural prions from sheep</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Vienna</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>Investigation of human prion disease</gtr:description><gtr:id>ADF66FE4-34D2-4B8E-BECD-34933410A0DA</gtr:id><gtr:impact>PMID:16597650</gtr:impact><gtr:outcomeId>82ABE99C419-1</gtr:outcomeId><gtr:partnerContribution>Provision of samples and neuropathological analysis</gtr:partnerContribution><gtr:piContribution>Collaborative research on human prion disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Birkbeck, University of London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Structural and Molecular Biology</gtr:department><gtr:description>Investigation of prion structure</gtr:description><gtr:id>766822E7-162D-4036-A767-F73FE569133E</gtr:id><gtr:impact>Publication
PMID:24022506</gtr:impact><gtr:outcomeId>UUty5km7UyK-1</gtr:outcomeId><gtr:partnerContribution>Electron microscopy</gtr:partnerContribution><gtr:piContribution>Generation of purified proteins for electron microscopy</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Derriford Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Histopathology</gtr:department><gtr:description>Investigation of human prion disease</gtr:description><gtr:id>FDAC9C2C-A1FF-40DC-B153-66F02E29DFE7</gtr:id><gtr:impact>PMID:21294124</gtr:impact><gtr:outcomeId>X1wruHgUYre-1</gtr:outcomeId><gtr:partnerContribution>Provision of tissue specimens and expert opinion</gtr:partnerContribution><gtr:piContribution>Investgation of human tissue samples</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The National Creutzfeldt-Jakob Disease Research &amp; Surveillance Unit</gtr:department><gtr:description>Investigation of human prion disease</gtr:description><gtr:id>EA84AAF2-390A-4B7B-BB4F-F153D6C98539</gtr:id><gtr:impact>PMID:21294124</gtr:impact><gtr:outcomeId>KNzyycdAziU-1</gtr:outcomeId><gtr:partnerContribution>Provision of tissue specimens and expert opinion</gtr:partnerContribution><gtr:piContribution>Investigation of human tissue samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Interaction with journalists</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BEF3D8E9-DC7E-46A0-81BD-8FED14A703C2</gtr:id><gtr:impact>Preparation of MRC press releases and interaction with journalists covering our research.

Interaction with the media led to the following web links covering our research http://news.bbc.co.uk/1/hi/health/6217296.stm http://news.bbc.co.uk/1/hi/health/7167866.stm http://www.mrc.ac.uk/Newspublications/News/MRC004444</gtr:impact><gtr:outcomeId>EB7662FA3C4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.insight.mrc.ac.uk/2015/03/12/behind-the-picture-proving-the-link-between-bse-and-vcjd/</gtr:url><gtr:year>2006,2007,2008,2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interaction with patients</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FE06FE32-69DF-466A-98AC-622953D07AE9</gtr:id><gtr:impact>Presentation to patients, policy-makers and healthcare professionals as part of the Centenary of the UK Medical Research Council. National Prion Clinic Open Day, London.

Positive written resonses from patients and family members</gtr:impact><gtr:outcomeId>gdYvqCEceTm</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Member of the World Health Organisation International Expert Consultation Group for Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies (2005-ongoing)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F7E79CC3-AF31-4EFE-AB0A-D6612497CA8E</gtr:id><gtr:impact>Scientific advisor. Provided scientific data following an oral presentation at an international meeting at WHO Headquarters, Geneva in 2005. Contributed to resulting World Health Organisation guidelines in 2006.

Contributed to publication of World Health Organisation guidelines. http://www.who.int/bloodproducts/cs/TSEPUBLISHEDREPORT.pdf</gtr:impact><gtr:outcomeId>E854C691828</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:url>http://www.who.int/bloodproducts/cs/TSEPUBLISHEDREPORT.pdf</gtr:url><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interaction with a patient group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B19B7D93-B522-4045-9500-677FCAB72834</gtr:id><gtr:impact>PhD studentship receives an endowment from the CJD Support Network. Regular written and verbal research updates are provided to CJDSN. http://www.cjdsupport.net/UserFiles/File/CJD%20news%200408%20final%20print%20version.pdf http://www.cjdsupport.net/UserFiles/File/CJD%20news%200409.pdf

Provision of support to patients and families affected by CJD.</gtr:impact><gtr:outcomeId>8090B3C961B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Member of the UK and Irish Transfusion Services Prion Working Group (2008-ongoing.</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>07989E26-B3CA-4181-96B3-CB73FA604AC1</gtr:id><gtr:impact>Scientific advisor.

Influence on healthcare policy decisions regarding the impact of vCJD to the blood transfusion service.</gtr:impact><gtr:outcomeId>A7DBF7C309A</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Member of the UK Health Protection Agency Expert Advisory Group on the Laboratory Testing Strategy for Large Scale Abnormal Prion Prevalence Studies (2006-0ngoing).</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B3887CE0-73E6-46F4-9ABB-B523218288C7</gtr:id><gtr:impact>Scientific advisor. Provision of research materials. Conducted support research.

Contribution to understanding the population prevalence of vCJD infection. Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. PMID: 19460798</gtr:impact><gtr:outcomeId>D9C57D02C4C</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the World Health Organisation International Expert Consultation Group for Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>4495746A-77ED-431B-B896-EA0FF9BC5F54</gtr:id><gtr:impact>Provision of worldwide guidance to help minimize or eliminate the risk for transmitting BSE and vCJD to humans via biologicals and other medicinal products. http://www.who.int/bloodproducts/cs/TSEPUBLISHEDREPORT.pdf</gtr:impact><gtr:outcomeId>FB8F1AD2B0A</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>http://www.who.int/bloodproducts/cs/TSEPUBLISHEDREPORT.pdf</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the UK Health Protection Agency Expert Advisory Group on the Laboratory Testing Strategy for Large Scale Abnormal Prion Prevalence Studies (2006-0ngoing).</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>33DBD619-B51A-4EA3-9D4E-E1D3AD2E3289</gtr:id><gtr:outcomeId>9913B1B89F8</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19460798</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the UK and Irish Blood Transfusion Services Prion Working Group.</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>4429C246-21DB-4AAD-B264-75662B6E7D7B</gtr:id><gtr:outcomeId>5966FF93A0D</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Improvement of existing methods. Described in Wadsworth JDF, Powell C, Beck JA, Joiner S, Linehan JM, Brandner S, Mead S, Collinge J. (2008) Molecular diagnosis of human prion disease. Methods in Molecular Biology 459: 197-227. PMID:18576157 Cronier S, Gros N, Tattum H, Jackson GS, Clarke AR, Collinge J, Wadsworth JDF. Detection and characterization of proteinase K-sensitive disease related prion protein with thermolysin. Biochem J 2008; 416: 297-305. PMID:18684106</gtr:description><gtr:id>9B2CAC15-AF62-4DBF-BBCB-3E2E8B68D01F</gtr:id><gtr:impact>Methods are in worldwide use to aid with diagnosis of human and animal prion disease.</gtr:impact><gtr:outcomeId>80F1E082C4F</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Improved methods for diagnosis of prion disease</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://europepmc.org/abstract/MED/18576157</gtr:url><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>14E15706-2B77-4830-87D0-BF29203DB3CD</gtr:id><gtr:title>Ex vivo mammalian prions are formed of paired double helical prion protein fibrils.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/90030108a9bdcf2055469e0536a26b1e"><gtr:id>90030108a9bdcf2055469e0536a26b1e</gtr:id><gtr:otherNames>Terry C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>58989b9d890413.85017695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>92B95CE9-046D-46DF-8BA1-8DCFC6DB6BFD</gtr:id><gtr:title>Inhibition of proteinase K activity by copper(II) ions.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8b3c0d274c9d3ef761e989e7a43f3c0a"><gtr:id>8b3c0d274c9d3ef761e989e7a43f3c0a</gtr:id><gtr:otherNames>Stone LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>A9F971930F4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70A12DEF-83F4-4829-9D2C-C282A82641C6</gtr:id><gtr:title>Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25db88fcbd041997bffe5354e9a3b87e"><gtr:id>25db88fcbd041997bffe5354e9a3b87e</gtr:id><gtr:otherNames>Wadsworth JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>Zj9NaGKCiEz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7A2EEC4-5993-4C23-AFB7-5325228CDBF6</gtr:id><gtr:title>Creutzfeldt-Jakob disease, prion protein gene codon 129VV, and a novel PrPSc type in a young British woman.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>ckb31f5posj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8778DFFF-D0FE-4C24-AEA0-75784D6F6221</gtr:id><gtr:title>Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c101120111e9f19df81b4f0bdae6dff"><gtr:id>8c101120111e9f19df81b4f0bdae6dff</gtr:id><gtr:otherNames>Sandberg MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>gb81abMKZFg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D51C313-2B7E-4D25-8157-34FB514EB10D</gtr:id><gtr:title>Evidence for human transmission of amyloid-? pathology and cerebral amyloid angiopathy.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/46f5fbd4a8def22591a116738bda4515"><gtr:id>46f5fbd4a8def22591a116738bda4515</gtr:id><gtr:otherNames>Jaunmuktane Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56b1fc2c284001.62577337</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9C12BCA0-9605-46F2-9E57-99983D5B6092</gtr:id><gtr:title>Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d192d2dafa2cf2bba24756bcdaf8689b"><gtr:id>d192d2dafa2cf2bba24756bcdaf8689b</gtr:id><gtr:otherNames>D'Castro L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>dGZ33Cmh2SJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7505266-C216-4446-BC59-8DB3F3A41D41</gtr:id><gtr:title>Soluble A? aggregates can inhibit prion propagation.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/879894f040f3812d62b2ae898fd16aa4"><gtr:id>879894f040f3812d62b2ae898fd16aa4</gtr:id><gtr:otherNames>Sarell CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>5a819b532e7bc7.28168587</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E910116-4746-415C-AFE7-4BBEC766FB3A</gtr:id><gtr:title>Physical, chemical and kinetic factors affecting prion infectivity.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e107587b5118dadea420a7a7c6a23acc"><gtr:id>e107587b5118dadea420a7a7c6a23acc</gtr:id><gtr:otherNames>Properzi F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn><gtr:outcomeId>58989b9dac8db6.75128998</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48A162C0-ECF3-429E-B0A6-76CFAA45B60C</gtr:id><gtr:title>Methods for Molecular Diagnosis of Human Prion Disease.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6d7fd37105cd0306c02155d831a1698"><gtr:id>c6d7fd37105cd0306c02155d831a1698</gtr:id><gtr:otherNames>Wadsworth JDF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>5a819b5300f491.17718834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>551F92A5-B220-4496-BBAB-030DCDF28C85</gtr:id><gtr:title>Heterozygosity at polymorphic codon 219 in variant creutzfeldt-jakob disease.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44154794c63211aac745864409e98d53"><gtr:id>44154794c63211aac745864409e98d53</gtr:id><gtr:otherNames>Lukic A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>nkziMopnGhE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>470B1D00-96C2-41E2-8035-54208BE0C219</gtr:id><gtr:title>Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c101120111e9f19df81b4f0bdae6dff"><gtr:id>8c101120111e9f19df81b4f0bdae6dff</gtr:id><gtr:otherNames>Sandberg MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>544f771557bd05.81322283</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD9AF81B-76CD-4689-AA1C-D035808CF7CE</gtr:id><gtr:title>Molecular diagnosis of human prion disease.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25db88fcbd041997bffe5354e9a3b87e"><gtr:id>25db88fcbd041997bffe5354e9a3b87e</gtr:id><gtr:otherNames>Wadsworth JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>hWDf85vjGPR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E742CE8-9A01-4E95-BEDB-827C09EF47C1</gtr:id><gtr:title>Amyloid-? nanotubes are associated with prion protein-dependent synaptotoxicity.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47d5e240428d904766fabe26c08463fd"><gtr:id>47d5e240428d904766fabe26c08463fd</gtr:id><gtr:otherNames>Nicoll AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_15516_26_24022506</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>25051A2D-5952-43B3-BB94-D6B39D70CE5E</gtr:id><gtr:title>Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2425c10daa4923f9040e1a5332915e6e"><gtr:id>2425c10daa4923f9040e1a5332915e6e</gtr:id><gtr:otherNames>Kaski DN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>mQCNN9ASzjs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F312E4F-90F9-4B20-9069-0B2145D61F59</gtr:id><gtr:title>Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25db88fcbd041997bffe5354e9a3b87e"><gtr:id>25db88fcbd041997bffe5354e9a3b87e</gtr:id><gtr:otherNames>Wadsworth JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>kF1nR998uh8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C96AF508-C2A7-4DE1-ACF7-B25EEBC19805</gtr:id><gtr:title>Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48400a296d38fca43225c28bd85f67c0"><gtr:id>48400a296d38fca43225c28bd85f67c0</gtr:id><gtr:otherNames>Reiniger L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>544f7715d01232.97244026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABC502C5-570C-4E62-9C21-047755A86014</gtr:id><gtr:title>Molecular pathology of human prion disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25db88fcbd041997bffe5354e9a3b87e"><gtr:id>25db88fcbd041997bffe5354e9a3b87e</gtr:id><gtr:otherNames>Wadsworth JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>Y5RaMwhfvp3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7E053BAC-10B2-4F39-9EB1-0EE4E1E0831C</gtr:id><gtr:title>Variant Creutzfeldt-Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/809b4086fcbd8d5c1c06308f735111f0"><gtr:id>809b4086fcbd8d5c1c06308f735111f0</gtr:id><gtr:otherNames>Mok T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>58989b9dcae9b3.59587676</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>968FE5E1-E2C1-43BA-8F6C-59C4F828CD0D</gtr:id><gtr:title>Atypical scrapie prions from sheep and lack of disease in transgenic mice overexpressing human prion protein.</gtr:title><gtr:parentPublicationTitle>Emerging infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25db88fcbd041997bffe5354e9a3b87e"><gtr:id>25db88fcbd041997bffe5354e9a3b87e</gtr:id><gtr:otherNames>Wadsworth JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1080-6040</gtr:issn><gtr:outcomeId>pm_15516_26_24188521</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27C495E1-4E39-44C0-A660-7196283361DB</gtr:id><gtr:title>A systematic investigation of production of synthetic prions from recombinant prion protein.</gtr:title><gtr:parentPublicationTitle>Open biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b2740857e0a6a774e56992f6a12381e"><gtr:id>7b2740857e0a6a774e56992f6a12381e</gtr:id><gtr:otherNames>Schmidt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2046-2441</gtr:issn><gtr:outcomeId>56b1fc2b5bc124.95645962</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66CC7C9E-E3E7-4228-84F7-BC845B73E667</gtr:id><gtr:title>Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ecb95f24c0e9454b353263ea6230fa92"><gtr:id>ecb95f24c0e9454b353263ea6230fa92</gtr:id><gtr:otherNames>Webb TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>Mu8i4RQxj2J</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAD87362-D1A8-473B-9CBF-23934D226BC3</gtr:id><gtr:title>A novel prion disease associated with diarrhea and autonomic neuropathy.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>544f771622e247.43302526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8374C266-F1CF-46B7-949E-DC61D299B489</gtr:id><gtr:title>Experimental sheep BSE prions generate the vCJD phenotype when serially passaged in transgenic mice expressing human prion protein.</gtr:title><gtr:parentPublicationTitle>Journal of the neurological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c6b0f825cf34f269514039fa9fcb879"><gtr:id>2c6b0f825cf34f269514039fa9fcb879</gtr:id><gtr:otherNames>Joiner S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0022-510X</gtr:issn><gtr:outcomeId>5a819b53eab9b4.28107346</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5FE2090-638C-4779-9D4C-9F82A1B92ACC</gtr:id><gtr:title>Inherited prion disease with 5-OPRI: phenotype modification by repeat length and codon 129.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>n7Vz9s54d4k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA74710A-DC5A-402E-AA44-823D4E174B6E</gtr:id><gtr:title>Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25db88fcbd041997bffe5354e9a3b87e"><gtr:id>25db88fcbd041997bffe5354e9a3b87e</gtr:id><gtr:otherNames>Wadsworth JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>LcehncbwoPi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B945261-1417-442A-B888-9D8E09935CA6</gtr:id><gtr:title>Variant Creutzfeldt-Jakob disease with extremely low lymphoreticular deposition of prion protein.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>544f77158f7418.78397926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB1070EF-F59C-4800-8AD7-09C478D2F203</gtr:id><gtr:title>Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>56d5b1dade02b0.09485022</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D76A13A-4893-4EBE-B108-42F6CC3D6628</gtr:id><gtr:title>Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d33325db7c1bbd99fe8b86ca728e230"><gtr:id>6d33325db7c1bbd99fe8b86ca728e230</gtr:id><gtr:otherNames>Asante EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>56b1fc2c92dd42.43495306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D77AEFCD-B014-45BC-A772-B915C0336DE8</gtr:id><gtr:title>Review. The origin of the prion agent of kuru: molecular and biological strain typing.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25db88fcbd041997bffe5354e9a3b87e"><gtr:id>25db88fcbd041997bffe5354e9a3b87e</gtr:id><gtr:otherNames>Wadsworth JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>P5Y185SASp3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51205FC2-418F-4514-8A04-4BAE07AC7A9D</gtr:id><gtr:title>Inherited prion disease with six octapeptide repeat insertional mutation--molecular analysis of phenotypic heterogeneity.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbee40658e79cab5d825627f276ab357"><gtr:id>cbee40658e79cab5d825627f276ab357</gtr:id><gtr:otherNames>Mead S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>r2KY7QiE4vV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE93D33A-E418-4608-9209-015F11AFBC11</gtr:id><gtr:title>Seven-year discordance in age at onset in monozygotic twins with inherited prion disease (P102L).</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc91402d504020448ea53946ad57bcaa"><gtr:id>fc91402d504020448ea53946ad57bcaa</gtr:id><gtr:otherNames>Webb T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>muNgtoQQWgx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30F017D4-3655-4AFE-AAEA-1F7D2317C84E</gtr:id><gtr:title>Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/124a2925167cbee690b074d32a622cc8"><gtr:id>124a2925167cbee690b074d32a622cc8</gtr:id><gtr:otherNames>Brandner S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>575E4328AE0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C91D9E6-C968-49D4-BF43-52293B5662A4</gtr:id><gtr:title>Review: contribution of transgenic models to understanding human prion disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25db88fcbd041997bffe5354e9a3b87e"><gtr:id>25db88fcbd041997bffe5354e9a3b87e</gtr:id><gtr:otherNames>Wadsworth JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>sEL9vHjdPdx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>215F3CEE-3B60-4973-A04E-EDED8133CCD3</gtr:id><gtr:title>A naturally occurring variant of the human prion protein completely prevents prion disease.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d33325db7c1bbd99fe8b86ca728e230"><gtr:id>6d33325db7c1bbd99fe8b86ca728e230</gtr:id><gtr:otherNames>Asante EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56b1fc2cc661f3.09813868</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E8F46DD-3670-4520-9936-8FAD8F6C3EF6</gtr:id><gtr:title>Inherited prion disease A117V is not simply a proteinopathy but produces prions transmissible to transgenic mice expressing homologous prion protein.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d33325db7c1bbd99fe8b86ca728e230"><gtr:id>6d33325db7c1bbd99fe8b86ca728e230</gtr:id><gtr:otherNames>Asante EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>pm_15516_26_24086135</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC50BAF3-181B-45CF-9A40-8055062D9AAC</gtr:id><gtr:title>First report of Creutzfeldt-Jakob disease occurring in 2 siblings unexplained by PRNP mutation.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ecb95f24c0e9454b353263ea6230fa92"><gtr:id>ecb95f24c0e9454b353263ea6230fa92</gtr:id><gtr:otherNames>Webb TE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>Coe6mDqxbge</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5062C99D-9CEA-4F3B-9869-F57C245109B0</gtr:id><gtr:title>Prion infectivity in variant Creutzfeldt-Jakob disease rectum.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25db88fcbd041997bffe5354e9a3b87e"><gtr:id>25db88fcbd041997bffe5354e9a3b87e</gtr:id><gtr:otherNames>Wadsworth JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>ragPVzihByi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D07999B-F407-40A4-B7B6-17FC32CB2B71</gtr:id><gtr:title>Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d33325db7c1bbd99fe8b86ca728e230"><gtr:id>6d33325db7c1bbd99fe8b86ca728e230</gtr:id><gtr:otherNames>Asante EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>KHE419q59MX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A9F9C9E5-C732-4D98-BBAE-8841D22CD5E8</gtr:id><gtr:title>Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01510dcd2c16ce1aeba88470243237a4"><gtr:id>01510dcd2c16ce1aeba88470243237a4</gtr:id><gtr:otherNames>Rudge P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>56b1fc2c5bec04.57133416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F2BCB11-BF45-4AAF-8306-2E434BEA0A4A</gtr:id><gtr:title>Spontaneous generation of mammalian prions.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d7b7e2fe78d5e2742820eea3aa14ddd"><gtr:id>5d7b7e2fe78d5e2742820eea3aa14ddd</gtr:id><gtr:otherNames>Edgeworth JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>HjkxWNrDENg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>528D36AC-8066-43C3-8EF8-1A12F2E206D3</gtr:id><gtr:title>Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/53740aa86cab452a475ba97e3f46e1b0"><gtr:id>53740aa86cab452a475ba97e3f46e1b0</gtr:id><gtr:otherNames>Cronier S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>2B1FF4C332B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35DFD037-21ED-48B7-8AF7-EA0CC1869CA4</gtr:id><gtr:title>Update on human prion disease.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25db88fcbd041997bffe5354e9a3b87e"><gtr:id>25db88fcbd041997bffe5354e9a3b87e</gtr:id><gtr:otherNames>Wadsworth JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>AC9876F750F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68BA2025-58E2-4BAE-BB41-9F35F99D671A</gtr:id><gtr:title>Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dd1ab8c581b76bf8fd748515a9becb00"><gtr:id>dd1ab8c581b76bf8fd748515a9becb00</gtr:id><gtr:otherNames>Wroe SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>79D84A647EF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B8A803B-AB6F-4243-8F2E-CC06ED0B4A98</gtr:id><gtr:title>A novel and rapid method for obtaining high titre intact prion strains from mammalian brain.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f50216d5b995f1fbaf35e380b123fd6c"><gtr:id>f50216d5b995f1fbaf35e380b123fd6c</gtr:id><gtr:otherNames>Wenborn A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56b1fc2d29a8f5.02053912</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A39419DC-D9C9-4CBF-B15F-B9C7F476D952</gtr:id><gtr:title>Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d33325db7c1bbd99fe8b86ca728e230"><gtr:id>6d33325db7c1bbd99fe8b86ca728e230</gtr:id><gtr:otherNames>Asante EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>a34unQWQbMK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C081D851-3938-4C28-B492-94032B9A4971</gtr:id><gtr:title>Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d451a50d5a8944d10f811aa73a12d437"><gtr:id>d451a50d5a8944d10f811aa73a12d437</gtr:id><gtr:otherNames>Hill AF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>B7A62934292</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U123160655</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>